OM
Opaleye Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-395,276
| Closed | -$23M | – | 45 |
|
|
2024
Q3 | $23M | Buy |
395,276
+27,776
| +8% | +$1.61M | 3.83% | 7 |
|
|
2024
Q2 | $16.8M | Hold |
367,500
| – | – | 3.84% | 5 |
|
|
2024
Q1 | $24.3M | Buy |
367,500
+10,000
| +3% | +$662K | 5.3% | 4 |
|
|
2023
Q4 | $14.2M | Sell |
357,500
-2,900
| -0.8% | -$115K | 3.78% | 7 |
|
|
2023
Q3 | $11.5M | Buy |
360,400
+7,750
| +2% | +$247K | 3.74% | 7 |
|
|
2023
Q2 | $14.2M | Buy |
352,650
+114,650
| +48% | +$4.61M | 3.39% | 6 |
|
|
2023
Q1 | $10.2M | Hold |
238,000
| – | – | 3.04% | 7 |
|
|
2022
Q4 | $11.4M | Sell |
238,000
-83,300
| -26% | -$4M | 3.97% | 7 |
|
|
2022
Q3 | $12.1M | Buy |
321,300
+45,300
| +16% | +$1.7M | 4.99% | 7 |
|
|
2022
Q2 | $7.63M | Buy |
276,000
+10,250
| +4% | +$283K | 3.44% | 11 |
|
|
2022
Q1 | $14.5M | Hold |
265,750
| – | – | 4.49% | 7 |
|
|
2021
Q4 | $15.5M | Sell |
265,750
-86,750
| -25% | -$5.08M | 3.3% | 11 |
|
|
2021
Q3 | $13.9M | Buy |
352,500
+117,500
| +50% | +$4.65M | 2.6% | 12 |
|
|
2021
Q2 | $9.98M | Buy |
235,000
+77,500
| +49% | +$3.29M | 1.66% | 19 |
|
|
2021
Q1 | $9.69M | Buy |
+157,500
| New | +$9.69M | 1.42% | 20 |
|